CVS Caremark, the pharmacy benefit manager (PBM) arm of CVS Health, has released a new study conducted in partnership with Employee Benefit News that examines the evolving role of PBMs in managing corporate pharmacy benefits. The survey of HR decision-makers and executive leaders reveals a landscape where employers are deeply anxious about escalating drug prices, with an overwhelming 91% expressing concern over medication costs for their workforce. This data underscores a pivotal shift in employer expectations, as 88% of respondents now view their PBM as uniquely positioned to wield its purchasing power and market expertise to combat these financial pressures.
As part of this research, Employee Benefit News and CVS Caremark identified three primary avenues where employers are seeking relief — implementing sustainable strategies for costly GLP-1 weight management drugs, accelerating the adoption of more affordable biosimilar alternatives, and leveraging digital technology to both personalize the member experience and streamline administrative processes.
Image Credit: CVS Caremark
Key Themes Behind This Trend
- Employer Drug Cost Control
- Rising anxiety over workforce medication expenses is creating demand for pharmacy benefit models that use purchasing leverage, transparent pricing, and clinical strategy to reduce corporate healthcare costs.
- GLP-1 Benefit Management
- The rapid growth of weight management drugs is reshaping benefits design around eligibility rules, adherence support, and long-term cost sustainability for employers.
- Digital Pharmacy Personalization
- Personalized digital tools are expanding the role of PBMs by improving member guidance, simplifying administration, and linking pharmacy benefits more closely to employee experience.
Where This Applies
- Pharmacy Benefit Management
- PBMs are positioned to evolve from claims administrators into strategic cost-management partners as employers seek stronger negotiation power and medication access expertise.
- Employee Benefits
- Corporate benefits programs are becoming more data-driven as HR leaders balance employee health expectations with financial pressure from specialty and chronic-care medications.
- Biopharmaceuticals
- Biosimilar adoption is opening competitive space for manufacturers, payers, and benefits platforms that can accelerate lower-cost alternatives without reducing perceived care quality.
